Novel Therapeutic Approaches in Neuroendocrine Tumors
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 840
Special Issue Editor
Interests: molecular endocrinology; mouse modelling; phosphodiesterases; neuroendocrine tumors; metabolic disorders; developmental biology; cancer research
Special Issue Information
Dear Colleagues,
Neuroendocrine tumors (NETs) are a heterogeneous class of neoplasms arising from the diffuse neuroendocrine system that may occur at many different anatomical sites. Management of NETs represents a clinical challenge because of their late onset and absence of selective biomarkers. High-grade tumors are often treated with cytotoxic chemotherapy, while low-grade tumors are usually treated with somatostatin analogs as well as radio-conjugated somatostatin analogs. Although these approaches have proven effective in slowing tumor growth their efficacy is limited to specific patient populations. This Special Issue aims to address recent advances in the development of new therapeutic strategies for the treatment of NETs.
Dr. Federica Campolo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroendocrine tumors (NET)
- gastroenteropancreatic tumors (GEP-NET)
- pheochromocytoma
- paraganglioma
- carcinoids
- Merkel cell carcinoma (MCC)
- small cell lung cancer (SCLC)
- large cell neuroendocrine carcinoma (LCNC)
- medullary thyroid carcinoma (MTC)
- neuroendocrine prostate cancer (NEPC)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
